Skip to content

Clinical trials

Completed Graves Ophthalmopathy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graves Ophthalmopathy Status: Completed Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20052
20061
20071
20081
20101
20114
20125
20134
20142
20155
20161
20177
20183
20191
20207
20216
20226
20239
20246
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen10
University of Pisa7
Viridian Therapeutics, Inc.5
Medical University of Warsaw4
Immunovant Sciences GmbH3
Innovent Biologics (Suzhou) Co. Ltd.3
Hoffmann-La Roche2
Instituto de Oftalmología Fundación Conde de Valenciana2
Medical University of Sofia2
Medical University of Vienna2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graves Ophthalmopathy80
Graves Disease19
Exophthalmos7
Eye Diseases6
Thyroid Diseases5
Autoimmune Diseases4
Endocrine System Diseases3
Heart Failure2
Hypercholesterolemia2
Hypertension2

Trials

Showing 51 to 75 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.